AI Biomed PredictionsATNM – Actinium Set for Breakout Amid Pivotal Trial Updates Tony Fogleman / July 5, 2025
AI Biomed PredictionsPLX – Protalix Poised for Breakout with Upcoming FDA Approvals Tony Fogleman / July 5, 2025
AI Biomed PredictionsCRBP – Corbus Pharmaceuticals: Poised for Breakthrough with CRB-913 Tony Fogleman / July 5, 2025
AI Biomed PredictionsCVM – Multikine Nears Approval, Cel-Sci Poised for Breakout Tony Fogleman / July 5, 2025
AI Biomed PredictionsPULM – Strategic Merger and Clinical Advances Propel Pulmatrix Tony Fogleman / July 5, 2025
AI Biomed PredictionsOGEN – Oragenics Set for Breakout Amid Promising ONP-002 Phase 2 Trials Tony Fogleman / July 5, 2025
AI Biomed PredictionsSCYX – SCYNEXIS Set for Breakout Amid Promising Trial Outcomes Tony Fogleman / July 5, 2025
AI Biomed PredictionsLPCN – Lipocine Eyes Breakthrough with Upcoming FDA Decision Tony Fogleman / July 5, 2025
AI Biomed PredictionsFGEN – FibroGen Poised for Recovery with Key Trial Updates Tony Fogleman / July 4, 2025
AI Biomed PredictionsMEIP – MEI Pharma Poised for Breakout with Upcoming Clinical Results Tony Fogleman / July 4, 2025
